The Market Herald Interview Discussing First-of-its-Kind Magnetic Imaging Technology

We recently announced that our MagSense® diagnostic technology has the potential to target prostate cancer tumors, making this the second cancer type the…


Health Industry Hub Interview

Bob Proulx sat down with Rozalina Sarkezians, Managing Director & Founder of Health Industry Hub, for a chat about Imagion Biosystem’s work developing our…


Ticker News Interview - Breast Cancer Clinical Trial Update

Bob Proulx discusses updates on the first-in-human MagSense® HER2 breast cancer clinical trial with TickerTV - trial is progressing positively.  …